Telryl M 40mg/47.5mg Tablet

Name: Telryl M 40mg/47.5mg Tablet
Brand: Alcia Pharma
Price: 98 INR

Prescription Required

Marketer

Alcia Pharma

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (47.5mg)

Overview Telryl M 40mg/47.5mg Tablet

Cardio-M 40mg/47.5mg tablets manage hypertension, reducing the risk of cardiovascular events like strokes and heart attacks. Early intervention improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food at the same time daily, as directed by your physician. Continued use is crucial, even with symptom absence, as hypertension is often asymptomatic. Discontinuing treatment can worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, further enhance blood pressure control. Adherence to your doctor's instructions is paramount. Potential side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), elevated potassium, shortness of breath, nausea, vomiting, stomach pain, and tiredness. Potassium-rich foods and supplements should be avoided. Dizziness may occur; avoid driving and rise slowly from seated positions. Regular monitoring of blood pressure, blood sugar, kidney function, and electrolyte levels may be required. Inform your doctor of any pre-existing liver or kidney conditions, and pregnant or breastfeeding individuals should seek medical counsel before use. Disclose all other medications, particularly those for hypertension or heart conditions.

Uses of Telryl M 40mg/47.5mg Tablet

Managing Elevated Blood Pressure

Major Benefits of Telryl M 40mg/47.5mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. It's recommended to take the Telryl M 40mg/47.5mg Tablet with food.

Common Side effects of Telryl M 40mg/47.5mg Tablet:

Headache
Weakness
Dizziness
Cold extremities
Slow heart rate
Increased potassium level in blood
Decreased blood pressure
Orthostatic hypotension (sudden lowering of blood pressure on standing)
Breathlessness
Vomiting
Abdominal pain

How to use Telryl M 40mg/47.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telryl M 40mg/47.5mg Tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medicine with a meal.

How Telryl M 40mg/47.5mg Tablet works:

Each Telryl M 40mg/47.5mg tablet combines telmisartan and metoprolol succinate, two agents that reduce blood pressure.

SAFETY ADVICE

AlcoholUNSAFE

Concurrent alcohol and Telryl M 40mg/47.5mg Tablet use poses a safety risk.

PregnancyCONSULT YOUR DOCTOR

Use of Telryl M 40mg/47.5mg tablets is contraindicated during pregnancy due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingSAFE IF PRESCRIBED

Lactation and the use of Telryl M 40mg/47.5mg tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.

DrivingUNSAFE

Taking Telryl M 40mg/47.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneySAFE IF PRESCRIBED

Patients with kidney disease can safely take Telryl M 40mg/47.5mg tablets without requiring any dosage modification.

LiverCAUTION

Patients with hepatic impairment should use Telryl M 40mg/47.5mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Telryl M 40mg/47.5mg Tablet :

Should you forget to take your Telryl M 40mg/47.5mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telryl M 40mg/47.5mg Tablet

Label	Value
Potential for Dependence	None.
Medication Classification	HEART

FAQs on Telryl M 40mg/47.5mg Tablet

Indeed, Telryl M 40mg/47.5mg Succinate tablets can induce dizziness. This side effect is often experienced upon standing after a period of lying down or sitting. To mitigate dizziness or fainting, stand gradually from a seated or recumbent position.

Adopting a healthier lifestyle complements the use of Telryl M 40mg/47.5mg Tablet Succinate. Quitting smoking is crucial, as it significantly raises the risk of cardiovascular events like heart attack and stroke. Weight management is important; individuals who are overweight or obese should strive for weight loss. A balanced diet rich in fruits and vegetables is recommended. Regular physical activity strengthens the heart and lowers the risk of heart attack.

Continue taking your prescribed Telryl M 40mg/47.5mg tablets as directed, even if you're feeling healthy. Abrupt discontinuation of Telryl M 40mg/47.5mg tablets can result in severe adverse events, including myocardial infarction and cerebrovascular accident.

Retain this medication in its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.

MRP 119

17% off

Inclusive of all taxes

Quantity:

of 10 Tablet

Telryl M 40mg/47.5mg Tabl...